Bausch Health is a diversified specialty pharmaceutical company with products spanning gastroenterology, hepatology, neurology, dermatology and other therapeutic areas. It markets branded prescription and certain consumer health products, often targeting chronic conditions and specialist-prescribed treatments. The business is oriented toward established pharmaceutical franchises rather than pure early-stage biotech discovery.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 2,530 | — | 148 | — |
| Q3 2025 | 2,681 | — | 179 | — |
| Q4 2025 | 2,796 | — | -112 | — |
| Q1 2026 | 2,524 | — | -1,423 | — |
| Q2 2026 | 2,852 | 12.7% | 258 | 74.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: LTC Properties, Inc. (LTC), Kennametal Inc. (KMT), Centrus Energy Corp. (LEU), InvenTrust Properties Corp. (IVT), Pitney Bowes Inc. (PBI), Grupo Aeromexico, S.A.B. de C.V (AERO)